Revalia Bio
Connecticut, United States · Biotechnology, research · 50 employees
Revalia Bio is transforming loss of a loved one into profound change in the world. We believe that organ donation for groundbreaking research holds the key to revolutionizing biomedical innovation. Because every donated organ provides a window into human health and disease that can unlock the rapid development of major medical breakthroughs.
Funding history
- Series seed — $14.5M — Sep 2025
- Funding Round — $12.3M — Nov 2024
Recent signals
- Sep 04, 2025: Raised $14.5M in Series seed
- Nov 06, 2024: Raised $12.3M
See plans & pricing → Track Revalia Bio’s funding, hiring, and signals — with verified contacts — on Fundz.